Product Information
ONDANSETRON ODT 8 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.1686 per EA under NDC 62135012230. Its NADAC has been published 226 times since Jun 8, 2022.
FDA first approved this application on Dec 26, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
8 mg/1
Manufacturer
Chartwell RX LLCNDC
62135012230
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ONDANSETRONApproval Type
Generic (ANDA)
FDA Application
ANDA077406FDA Approved
12/26/2006
TE Code
AB
On Market Since
12/26/2006
Pharmacological Classes
Price Statistics
The NADAC for ONDANSETRON ODT 8 MG TABLET has been published 226 times since Jun 8, 2022, and over the history we have for it it has declined 30.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1686 per EA |
|---|---|
| All-time high | $0.2436 (Jun 15, 2022) |
| All-time low | $0.1529 (Nov 20, 2024) |
| 52-week high | $0.1838 |
| 52-week low | $0.1616 |
| Median price | $0.1891 |
| Average price | $0.1910 |
| Largest weekly change | -24.1% (Nov 20, 2024) |
| Weeks tracked | 226 |
| Tracking since | Jun 8, 2022 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 54% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ondansetron market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-3 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ONDANSETRON ODT 8 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ONDANSETRON ODT 8 MG TABLET, manufactured by Chartwell RX LLC, is $0.1686 per EA (NDC 62135012230), effective Sep 30, 2026.
How has the price of ONDANSETRON ODT 8 MG TABLET changed over time?
Over the history we have for it, the NADAC for ONDANSETRON ODT 8 MG TABLET has declined 30.8%. It has been tracked across 226 weekly CMS publications since Jun 8, 2022.
What are the highest and lowest recorded NADAC prices for ONDANSETRON ODT 8 MG TABLET?
Since Jun 8, 2022, the NADAC for ONDANSETRON ODT 8 MG TABLET has ranged from a low of $0.1529 (Nov 20, 2024) to a high of $0.2436 (Jun 15, 2022), with a median of $0.1891 per EA.
Are there cheaper alternatives to ONDANSETRON ODT 8 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ONDANSETRON HCL 8 MG TABLET, is $0.0781 per EA — about 54% below ONDANSETRON ODT 8 MG TABLET.
Who manufactures ONDANSETRON ODT 8 MG TABLET?
ONDANSETRON ODT 8 MG TABLET (NDC 62135012230) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.